FOXO4 suppresses cisplatin resistance of Triple-Negative Breast Cancer by inhibiting autophagy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FOXO4 suppresses cisplatin resistance of Triple-Negative Breast Cancer by inhibiting autophagy

Published:2024-08 Issue: Volume: Page:
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

Zhu Yating,Zhang Chenguang,Yin Qiuyu,Xu Wenting,Luo Yulou,Ou Jianghua

Publisher

Elsevier BV

Reference55 articles.

1. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs;Bianchini;Nat Rev Clin Oncol,2022

2. Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review;Maqbool;Breast Cancer (Dove Med Press),2022

3. Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance);Boughey;Ann Surg,2017

4. Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts;Sharma;Clin Cancer Res,2017

5. TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer;Isakoff;J Clin Oncol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP